Bioavailability file: Ketoprofen

Fabad Journal of Pharmaceutical Sciences

Volumn 34, Issue 4, 2009, Pages 203-216

  Rençber, Seda ^a   Karavana, Sinem Yaprak ^a   Özyazici, Mine ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Bioavailability; Ketoprofen; Pharmacokinetics; Physicochemical properties; Stability

Indexed keywords

EID: 84859790535     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Mehanna A. NSAIDs: Chemistry and Pharmacological Actions. Am J Pharm Educ 67(2): article 63, 2003.
2. Hardman, JG, Limbird, LE. The Pharmacological Basis of Therapeutics, 9th Edition, New York, p.638.
3. Kantor, TG. Ketoprofen, A Review of Its Pharmacologic and Clinical Properties, Pharmacotherapy 6: 93-103, 1986. (Pubitemid 16003473)
4. Okai Tettey-Amlalo, RN. In Vitro Release of Ketoprofen from Proprietary and Extemporaneously Manufactured Gels, Rhodes University, A Thesis of Master, 2005.
5. Tayade, PT, Vavia, PR. Inclusion Complexes of Ketoprofen with β-Cyclodextrins: Oral Pharmacokinetics of Ketoprofen in Human, Indian J Pharm Sci 68: 164-170, 2006.
6. Vueba, ML, Batista de Carvalho, LAE., Veiga, F, Sousa, JJ, Pina, ME. Influence of Cellulose Ether Polymers on Ketoprofen Release from Hydrophilic Matrix Tablets, Eur J Pharm Biopharm 58: 51-59, 2004. (Pubitemid 38781004)
7. Katzung, BG. Basic and Clinical Pharmacology, Eighth Edition, San Francisco, p.605, 2000.
8. Remington's Pharmaceutical Sciences, 18th Edition, Mack Publishing Company,
9. Weder, JE, Dillon, CT, Hambley, TW, Kennedy, BJ, Lay, PA, Biffin, JR, Regtop, HL, Davies, NM. Copper complexes of non-steroidal anti- inflammatory drugs: an opportunity yet to be realized, Coordin Chem Rev 232: 95-126, 2002.
10. Hirohata, M, Ono, K, Morinaga, A, Yamada, M. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril- destabilizing effects for a-synuclein fibrils in vitro, Neuropharmacology 54: 620-627, 2008.
11. Üstünes, L. Rx-Media Pharma İnteraktif İlaç Bilgi Kaynaǧi, Ýzmir, 2011.
12. Martindale The Extra Pharmacopeia, 29th.Edition, The Pharmaceutical Press, London, p.1245, 1989.
13. Miles, S. Ketoprofen, Marshall University, Joan C. School of Medicine, Huntington, USA, 2007.
14. Marie, L, Ulf, A, Karin, L, Berit B. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration, Int J Pharm 284: 23-30, 2004.
15. Üner, M, Gönüllü, Ü, Yener, G, Altinkurt, T. A New Approach for Preparing a Controlled Release Ketoprofen Tablets by Using Beeswax, II Farmaco, 60: 27-31, 2005.
16. Sökmen, N, Uysal, S, Ayhan, F, Özyazici, M, Ayhan, H. Photopolymerized Poly(Ethylene Glycol) Diacrylate Hydrogels for Controlled Release of Ketoprofen, Hacet J B Chem 37(4): 337- 343, 2009.
17. Kheradmandnia, S, Vasheghani-Farahani, E, Nosrati, M, Atyabi, F. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax, Nanomed-Nanotechnol 6: 753-759, 2010.
18. Lu, WL, Zhang, Q, Zheng, L, Wang, H, Li, RY, Zhang, LF, Shen, WB, Tu, XD. Antipyretic, analgesic and anti-inflammatory activities of ketoprofen β-cyclodextrin ?nclusion complexes in animals, Biol Pharm Bull 27(10): 1515-1520, 2004.
19. http://www.drugs.com/pro/ketoprofen.html
20. Jamali, F, Brocks, DR. Clinical pharmacokinetics of ketoprofen and its enantiomers, Clin Pharmacokinet 19(3): 197-217, 1990. (Pubitemid 20281450)
21. Blanco, M, Gonzalez, JM, Torras, E, Valverde, I. Enantiomeric purity determination of ketoprofen by capillary electrophoresis: development and validation of the method, Anal Bioanal Chem 375: 157-163, 2003. (Pubitemid 41200857)
22. Lastra, CA, Nieto, A, Motilva, V, Martin, MJ, Herrerías, JM, Cabre, F, Mauleon, D. Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress, Inflamm Res 49: 627-632, 2000.
23. Vergote, GJ, Vervaet, C, Van Driessche, I, Hoste, S, Smedt, S, Demeester, J, Jain, RA, Ruddy, S, Remon, JP. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen, Int J Pharm 240: 79-84, 2002. (Pubitemid 34607704)
24. Sheng, JJ, Kasim, NA, Chandrasekharan, R, Amidon, GL. Solubilization and Dissolution of Insoluble Weak Acid, Ketoprofen: Effect of pH Combined Surfactant, Eur J Pharm Sci 29: 306- 314, 2006.
25. Löbenberg, R, Amidon, GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards, Eur J Pharm Biopharm 50: 3-12, 2000.
26. Maestrelli, F, Zerrouk, N, Cirri, M, Mennini, N, Mura, P. Microspheres for colonic delivery of ketoprofen-hydroxypropyl-βcyclodextrin complex, Eur J Pharm Sci 34:1-11, 2008.
27. Zakeri-Milani, P, Barzegar-Jalali, M, Azimi, M, Valizadeh, H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability, Eur J Pharm Biopharm 73: 102-106, 2009.
28. Ali, W, Williams, AC, Rawlinson, CF. Stochiometrically governed molecular interactions in drug: Poloxamer solid dispersions, Int J Pharm 391: 162-168, 2010.
29. Pickla, KE, Magnesa, C, Bodenlenza, M, Piebera, TR, Sinner, FM. Rapid online-SPE-MS/MS method for ketoprofen determination in dermal interstitial fluid samples from rats obtained by microdialysis or open-flow microperfusion, J Chromatogr B 850(1): 432-439, 2007. (Pubitemid 46618199)
30. Abd-el-Bary, A, Geneidy, A, Osman, A, Shalaby, S, Morshan, A, Solid state stability of ketoprofen in the presence of different excipients, Pharmazie. 54(3): 202-206, 1999. (Pubitemid 29135275)
31. European Pharmacopoeia 6.0, p.2218-2219.
32. Clarke's Isolation and Identification of Drugs, London: The Pharmaceutical Press, p.697-698, 1986.
33. British Pharmacopeia, The Stationery Office, London p.922,1464, 2005.
34. Bonazzi, D, Audrisano, V, Gatti, R, Cavrini, V. Analysis of pharmaceutical creams: a useful approach based on solid-phase extraction (SPE) and UV spectrophotometry, J Pharm Biomed Anal 13: 1321-1329, 1995.
35. Zhuang, Y, Song, H. Sensitive determination of ketoprofen using flow injection with chemiluminescence detection, J Pharm Biomed Anal 44: 824-828, 2007. (Pubitemid 47030772)
36. USP XXX-NF XXV, 2009, pp. 1090, 2439.
37. Iuliani, P, Carlucci, G, Marrone, A. Investigation of the HPLC response of NSAIDs by fractional experimental design and multivariate regression analysis. Response optimization and new retention parameters, J Pharm Biomed Anal 51: 46-55, 2010.
38. Donato, MG, Baeyens, W, Van Den Bossche, W, Sandra, P. The determination of non-steroidal antiinflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography, J Pharm Biomed Anal 12: 21-26, 1994. (Pubitemid 24073764)
39. Ozlu, C, Basan, H, Satana, E, Ertas, N, Goger, NG. Quantitative determination of ketoprofen in gels and ampules by using flow-injection UV spectrophotometry and HPLC, J Pharm Biomed Anal 39: 606-611, 2005. (Pubitemid 41196070)
40. Dvorak, J, Hajkova, R, Matysova, L, Novakova, L, Koupparis, MA, Solich, P. Simultaneous HPLC determination of ketoprofen and its degradation products in the presence of preservatives in pharmaceuticals, J Pharm Biomed Anal, 36: 625- 629, 2004.
41. Kemper, MS, Magnuson, EJ, Lowry, SR, McCarthy, WJ, Aksornkoae, N, Watts, DC, Johnson, JR, Shukla, AJ. Use of FT-NIR Transmission Spectroscopy for the Quantitative Analysis of an Active Ingredient in a Translucent Pharmaceutical Topical Gel Formulation, AAPS Pharm Sci 23(3): 81-85, 2001.
42. Bempong, DK, Bhattacharyya, A. Development and Validation of a Stability-Indicating High- Performance Liquid Chromatographic Assay for Ketoprofen Topical Penetrating Gel, J Chromatogr A 1073: 341-346, 2005. (Pubitemid 40544508)
43. Jalon, EG, Josa, M, Campanero, MA, Santoyo, S, Ygartua, P. Determination by high-performance liquid chromatography of ketoprofen in vitro in rat skin permaeation samples, J Chromatogr A 870: 143-149, 2000. (Pubitemid 30077418)
44. Blanco, M, Alcala, M, Bautista, M. Pharmaceutical gel analysis by NIR spectroscopy Determination of the active principle and low concentration of preservatives, Eur J Pharm Sci 33: 409-414, 2008.
45. Zholt K, Iryna, H, Yaroslav, B. Spectrophotometric Determination of Ketoprofen and Its Application in Pharmaceutical Analysis. Acta Poloniae Pharm Drug Res, 66(1): 3-9, 2009.
46. Aboul-Enein, HY, Dal, AG, Tuncel, M. A validated method development for ketoprofen by a flow- injection analysis with UV-detection and its application to pharmaceutical formulations, II Farmaco 58: 419-422, 2003. (Pubitemid 36593323)
47. Mohammad, A, Sharma, S, Bhawani, SA. Identification of Ketoprofen in Drug Formulation and Spiked Urine Samples by Micellar Thin Layer Chromatography and its Quantitative Estimation by High Performance Liquid Chromatography, Int J Pharm Tech Res 2(1): 89-96, 2010.
48. Sancin, P, Caputo, O, Cavallari, C, Passerini, N, Rodriguez, L, Cinib, M, Fini, A. Effects of ultrasound-assisted compaction on Ketoprofen/ Eudragit S100 Mixtures, Eur J Pharm Sci 7: 207- 213, 1999.
49. Cho?, S, Kim, S, Ryoo, JJ, Park, JY, Lee, KP. FT- Raman and FT-IR Spectra of the Non-steroidal Antiinflammatory Drug Ketoprofen Included in Cyclodextrins, Anal Sci 17: 85-88, 2001.
50. Abdel-Hamid, ME, Novotny, L, Hamza, H. Determination of Diclofenac Sodium, Flufenamic Acid, Indomethacin and Ketoprofen by LC- APCI-MS, J Pharm Biomed Anal 24: 587-594, 2001. (Pubitemid 32119574)
51. Moore, RA, Tramer, MR, Carroll, D, Wiffen, PJ, McQuay, HJ. Quantitative systematic review of topically, applied non-steroidal anti- inflammatory drugs, Br Med J 316: 333-338, 1998. (Pubitemid 28121255)
52. Sunshine, A, Olson, NZ, Zighelboim, I, Castro, A, Caracas, NY. Ketoprofen, acetaminophen plus oxycodone, and acetaminophen in the relief of postoperative pain, Clin Pharm Th 54: 546-555, 1993.
53. Li, KL, Vogel, R, Jeffcoat, MK, Alfano, MC, Smith, MA, Collins, JG, Offenbacher, S. The effect of ketoprofen creams on periodontal disease in rhesus monkeys, J Periodontal Res 31: 525, 1996.
54. Moretti MD, Gavini E, Peana AT. In vitro release and antiinflammatory activity of topical formulations of ketoprofen, Boll Chim Farm 139 (2): 67-72, 2000. (Pubitemid 30432082)
55. Rico H, Alamo C, Revilla M, Villa LF, Alguacil LF. Effect of adjuvant-induced arthritis on bone mass in rats and its prevention by non-steroid anti-inflammatory drugs (NSAIDs), Clin Exp Rheumatol 10: 595, 1992.
56. Ozaki, M, Minami, K, Sata, T, Shigematsu, A. Transdermal ketoprofen mitigates the severity of postoperative sore throat, Canad?an J Anesth 48: 1080-1083, 2001.
57. Dionne, RA, Gordon, SM, Tahara, M, Rowan, J, Troullos, E. Analgesic efficacy and pharmacokinetics of ketoprofen administered into a surgical site, The J Clin Pharm 39: 131-138, 1999. (Pubitemid 29068157)
58. Cannavino, CR, Abrams, LA, Palinkas, A, Saglimbeni, MD, Bracker, B. Efficacy of Transdermal Ketoprofen for Delayed Onset Muscle Soreness, Clin J Sport Med 13(4): 200-208, 2003. (Pubitemid 36917977)
59. James, U, Adelmun, MD, Richard D, Adelman, MD. Current Options for the Prevention and Treatment of Migraine, Clin Ther 23 (6): 772-788, 2001.
60. Hersh, EK, Moore, PA, Ross, GL. Over-the- Counter Analgesics and Antipyretics: A Critical Assessment, Cl?n Ther 22(5): 500-548, 2000. (Pubitemid 30434308)
61. Gürol, Z, Hekimoǧlu, S, Demirdamar, R, ?umnu, M. Percutaneous absorption of ketoprofen I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases, Acta Helv 71: 205, 1996.
62. Valenta, C, Wanka, M, Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug, J Control Release 63: 165-173, 2000. (Pubitemid 30046952)
63. Chen, X, Yueh-Lin C, Robert, O, Johnston, KP. Ketoprofen Nanoparticle Gels Formed by Evaporative Precipitation into Aqueous Solution, Am Inst Chem Eng 52(7): 2428-2435, 2006. (Pubitemid 44013406)
64. Rhee, YS, Choi, JG, Park, ES, Chi, SC. Transdermal delivery of ketoprofen using microemulsions, Int J Pharm 228: 161-170, 2001.
65. Green, GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone Sport Med 3: 50-59, 2001.
66. Villegas, I, Casa, C, Lastra, C, Motilva, V, Herrer?as, JM, Mart?n MJ. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: Role of prostaglandins and inflammatory response, Life Sci 74: 873-884, 2004. (Pubitemid 37501136)
67. White, S. Topical non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of inflammatory musculoskeletal disorders, Prostag Leukotr Ess 43: 209 - 222, 1991.
68. Evans, JM, MacDonald, TM. Tolerability of topical NSAIDs in the elderly. Do they really convey a safety advantage? Drugs Ageing 9: 101- 108, 1996.
69. Grahame, R. Transdermal non-steroidal anti- inflammatory agents, Brit J Clin Pract 49: 33-35, 1995.
70. Bagheri H, Lhiaubet V, Montastruc JL, Chouini- Lalanne N. Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data, Drug Saf 22(5): 339-49, 2000. (Pubitemid 30261078)
71. Bastien M, Milpied-Homsi B, Baudot S, Dutartre H, Litoux P. Ketoprofen-induced contact photosensitivity disorders: 5 cases, Ann Dermatol Vener 124(8): 523-6, 1997. (Pubitemid 27309843)
72. Tyson, K, Cobb, Pierce, JR, Amarillo. Acute Pancreatitis Associated with Ketoprofen, South Med J 85(4): 430-431, 1992.
73. Williams, RL, Upton, RA, Buskin, JN, Jones, RM. Ketoprofen-aspirin interactions, Clin Pharm Th 30: 226-231, 1981. (Pubitemid 12149143)
74. Waller, DG, Renwick, AG, Hillier, K. Medical pharmacology and therapeutics, second edition, Toronto, p. 367, 2005
75. Roda, A, Sabatini, L, Mirasoli, M, Baraldini, M, Roda, E. Bioavailability of a New Ketoprofen Formulation for Once-Daily Oral administration, Int J Pharm 241: 165-172, 2002. (Pubitemid 34667076)
76. Habib, MJ, Mesue, R. Development of controlled release formulations of ketoprofen for oral use, Drug Dev Ind Pharm 21: 1463-1472, 1995.
77. Upton, RA, Williams, RL, Guentert, TW, Buskin, JN, Riegelman, S. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay. Eur J Clin Pharm 20, 127-133, 1981.
78. Houghton, GW, Dennis, MJ, Rigler, ED. Comparative Pharmacokinetics of Ketoprofen Derived from single oral doses of Ketoprofen Capsules or a Novel Sustained-Release Pellet Formulation, Biopharm Drug Dispos 5: 203-209, 1984. (Pubitemid 14073506)
79. Mannila, A. Central Nervous System Permeation of Ibuprofen, Ketoprofen and Indomethacin, In Vivo and In Situ Studies in Rats and Clinical Trials in Children, Doctoral dissertation, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kuopio, 2009.
80. Yoshiharu, D, Hideki, H, Shinobu, F, Takafumi, N, Yoshinari, Y, Shizuo, Y, Ryohei, K. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for therapy of Alzheimer's disease. J Drug Target 8: 371-381, 2000.
81. Advenier, C, Annie, R, Gobert, C, Massias, P, Varoquaux, O, Flouvat, B. Pharmacokinetics of Ketoprofen in the Elderly, Br J clin Pharmac, 16: 65-70, 1983.
82. Upton, RA, Buskin, JN, Williams, RL, Holford, NHG, Riegelman, S. Negligible excretion of unchanged ketoprofen, naproxen and probenecid in urine, J Pharm Sci 69: 1254-1257, 1980.
83. http://www.drugs.com/pro/ketoprofen.html
84. Verbeeck, RK, Blackburn, JL, Loewen, GR. Clinical pharmacokinetics of nonsteroidal anti- inflammatory drugs, Clin Pharmacokin 8: 297-331, 1983. (Pubitemid 13069549)
85. Fletcher, D, Negre, I, Barbin, C, Francois, A, Carreres, C, Falgueirettes, C, Barboteu, A, Sami, K. Postoperative analgesia with i.v. paracetamol and ketoprofen combination after disc surgery, Can J Anaesth 44: 479-485, 1997. (Pubitemid 27317739)
86. Hyllested, M, Jones, S, Petersen, JL, Kehlet, H. Comparative effect of paracetamol, NSAID sor their combinationin postoperative pain management: a qualitative review, Br J Anaesth 88: 199-214, 2002. (Pubitemid 34144998)
87. Qiu, HX, Liu, J, Kong, H, Liu, Y, Mei, XG. Isobolographic analysis of the antinociceptive interactions between Ketoprofen and paracetamol, Eur J Pharm 557: 141-146, 2007. (Pubitemid 46186289)
88. Weiss, Y, Chenard, A, Kermadec, JM, Tertrain, F, Abitoboul M. Maintenance of Blood Pressure Control in Elderly Hypertensives on Ketoprofen, Scand J Rheumatol 20 (S91): 37-44, 1991.
89. Foster, RT, Jamali, F, Russell, AS. Pharmacokinetics of Ketoprofen enantiomers in cholecystectomy patients: influence of probenecid, Eur J Clin Pharmacol 37: 589-594, 1989. (Pubitemid 20025774)
90. Upton, RA, Williams, RL, Buskin, JN, Jones, RM. Effects of probenecid on ketoprofen kinetics, Clin Pharmacol Ther 31(6): 705-712, 1982. (Pubitemid 13096683)
91. Puglia, C, Blasi, P, Rizza, L, Schoubben, A, Bonina, F, Rossi, C, Ricci, M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm 357: 295-304, 2008. 1995.
92. Arida, AI, Al-Tabakha, MM. Encapsulation of ketoprofen for controlled drug release, Eur J Pharm Biopharm 66: 48-54, 2007. (Pubitemid 46412971)
93. Kenawy, ER, Abdel-Hay, FI, El-Newehy, MH, Wnek, GE. Controlled release of ketoprofen from electrospun poly(vinyl alcohol) nanofibers, Mater Sci Eng A 459: 390-396, 2007. (Pubitemid 46586132)
94. Xi, MM, Zhang, SQ, Wang, XY, Fang, KQ, Gu, Y. Study on the characteristics of pectin-ketoprofen for colon targeting in rats, Int J Pharm 298: 91-97, 2005. (Pubitemid 40828330)